Delayed second Pfizer Covid-19 shot produces more antibodies: Study
- The study looked at 175 people aged between 80 and 99
- Pfizer clinical trial had a three-week gap between doses
Pfizer's Covid-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study said.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more